Email Updates

You are here

10 March 2017 VOLUME 18 ISSUE 10

Media Coverage

  • Seen at the heart of fighting the HIV/AIDS epidemic....To end this pandemic, women are advancing research on the front lines as scientists in laboratories and clinics, as leaders of large, international clinical trial efforts, participants in clinical trials, [and] volunteering to help us better understand and fight the disease, one person at a time.

    March 8, 2017
  • The story of PEPFAR is not a success story yet. What it is, according to PEPFAR’s 13th report, which, along with the numbers, emphasizes themes of partnership, local participation, accountability, and equity, is a story of strategy, that if allowed to continue, will lead to success.

    March 7, 2017
    Science Speaks
  • Speaking during dissemination of the document..., Minister of State for Health, Dr. Osagie Ehanire said...that with dissemination of the guidelines everyone who tests positive to HIV is automatically eligible for treatment, all at risk of contracting HIV infection are to be offered antiretroviral drugs as prevention, all on treatment are entitled to at least one viral load test per year, and greater emphasis will be placed of care adjustable to the individual needs of patients.

    March 7, 2017
    Daily Trust
  • Thousands of HIV negative Kenyans will for the first time in history be placed on daily ARV pills this month to prevent infection. The pills will be given to those at high risk of contracting the virus, the Health ministry said on Tuesday....Martin Sirengo, head of the National AIDS and STI Control Programme, said trained health workers will assess who qualifies for this treatment, technically known as Preexposure prophylaxis (Prep).

    March 7, 2017
  • Zimbabwe has embarked on a new HIV study aimed at assessing if antibodies can be used to prevent contracting HIV from an infected partner if infused directly to a participant....In an interview during the Antibody Mediated Prevention (AMP) study update meeting recently in Cape Town, South Africa, protocol co-chairperson Dr Nyaradzo Mgodi, said this concept was similar to how vaccines for polio or chicken pox were developed.

    March 7, 2017
    Antibody Related Research
  • We found that the premiums pharmaceutical companies earn from charging substantially higher prices for their medications in the US compared to other Western countries generates substantially more than the companies spend globally on their research and development. This finding counters the claim that the higher prices paid by US patients and taxpayers are necessary to fund research and development.

    March 7, 2017
    Health Affairs Blog
  • At Harvard Medical School, research associate Navid Madani has spent years working with Iranian scientists on HIV/AIDS research. The collaboration builds expertise in Iran,...while Iranians share their knowledge on matters like needle exchange programs and methadone treatment centers. After the initial ban was announced, Madani and her team had to rethink how to bring students and scientists to the U.S....[Madani said] “The administration is throwing a lot of marbles for us to walk around instead of paying attention to serious security issues.”

    March 7, 2017
    Huffington Post
  • An HIV-positive bone marrow transplant recipient at the Mayo Clinic experienced prolonged viral remission lasting nearly 10 months – longer than the so-called Boston patients – after interrupting antiretroviral therapy (ART), according to a report at CROI 2017 last month. Although his viral load eventually rebounded, his HIV reservoirs appeared to be reduced.

    March 6, 2017
  • At CROI 2017, Morenike Ukpong-Folayan spoke with Mark Hubbard and Stacey Hannah about community concerns regarding medical research. The Good Participatory Practice (GPP) guidelines were serve as a "comprehensive, structured and strategic...scaffold" to be adapted to specific research.....Groups in South Africa are trying to incorporate these guidelines into ethics reviews of clinical trials....It is important that GPP not simply become a list of checkboxes to be ticked off, but a guide to meaningful engagement.

    March 6, 2017
  • In an CROI 2017, Kevin Fisher spoke with Ian Sanne and Kevin De Cock....The starting point for reaching WHO 90-90-90 goals is to reach key populations, such as adolescents and sex workers, for HIV testing. One approach for accomplishing this is self-testing; another is to offer HIV testing where such groups congregate....Compared to the cost of annual treatment, the investment made in simple in-house systems, mobile data collection platforms and data transmission platforms would be a small cost.

    March 6, 2017
  • We are now at another fork in the road for the AIDS pandemic. President Trump’s first budget proposal imperils the progress made over 13 years of PEPFAR and the Global Fund [and]....could cut foreign assistance spending by as much as 37 percent — meaning fewer people on HIV treatment, more preventable deaths, and greater instability around the world....Vice President Pence, President Trump, and Secretary of State Tillerson have publicly voiced their support for PEPFAR and the Global Fund.

    March 6, 2017
    The Hill
  • The event was organised on 6 March by the Global Health Centre at Geneva’s Graduate Institute....Each of the three remaining candidates--Tedros Adhanom Ghebreyesus (Ethiopia), Sania Nishtar (Pakistan) and David Nabarro (United Kingdom)--began with a three-minute outline of their political leadership vision for running the world health body.... It is clear that for three exceptionally qualified candidates the choice may largely come down to management style.

    March 6, 2017
    Intellectual Property Watch
  • Secretary of State Rex Tillerson's...formal appeal of the OMB's initial budget proposal seeks to restore some of the huge cuts proposed by the White House for State Department and foreign assistance funding....The bottom line is that funding for diplomacy and development will be the subject of a series of negotiations and likely fall somewhere between what the White House and Congress each want. Tillerson's challenge is to navigate between those two power centers and do as much as he can to defend the programs he believes in.

    March 3, 2017
    Washington Post
  • We, the members of the scientific and technical advisory group and the gender and rights advisory panel of the human reproduction programme (HRP) are deeply concerned at the growing opposition to sexual and reproductive health and rights....We fear that the significant gains made over the past three decades – maternal deaths almost halved, more women living with HIV on antiretroviral therapy, improved access to contraception services and information, and improved screening and treatment for women with cervical cancer – will be compromised.

    March 2, 2017
    The Guardian
  • On Friday, Utah's House Judiciary Committee voted to expand the state's definition of nonconsensual sex to include when a person with HIV who knows his or her status does not disclose it prior to sexual conduct. The bill would also increase penalties for other sexual offenses when the person convicted has HIV....In a hearing on the bill, Troy Williams, executive director of Equality Utah,...expressed concern that HB 369 could hamper efforts to prevent sexually transmitted infections, according to the Salt Lake Tribune.

    February 28, 2017
    The Body
  • There was a time in recent memory when scientists were very afraid of something called “advocacy”....Now, however, a large number of scientists and their supporters are poised to demonstrate on April 22, in an event that not only can be characterized as advocacy but that, despite its official nonpartisan stance, will surely be interpreted by some as a form of anti-Trump advocacy....The result is likely to be even more debate.

    February 27, 2017
    Washington Post

Published Research